TSXV - Free Realtime Quote CAD
NuGen Medical Devices Inc. (NGMD.V)
0.0150 -0.0050 (-25.00%)
As of 9:36:52 a.m. EDT. Market Open.
Chart Range Bar
Loading chart for NGMD.V
- Previous Close
0.0200 - Open
0.0150 - Bid 0.0150 x --
- Ask 0.0200 x --
- Day's Range
0.0150 - 0.0150 - 52 Week Range
0.0150 - 0.0600 - Volume
126,849 - Avg. Volume
124,843 - Market Cap (intraday)
3.406M - Beta (5Y Monthly) 1.58
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date (est.) Aug 27, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is based in Toronto, Canada.
www.nugenmd.com--
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Medical Devices
Industry
Recent News
View More
Performance Overview
Trailing total returns as of 2026-07-15, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
NGMD.V
50.00%
S&P/TSX Composite index (^GSPTSE)
10.89%
1-Year Return
NGMD.V
75.00%
S&P/TSX Composite index (^GSPTSE)
30.61%
3-Year Return
NGMD.V
92.68%
S&P/TSX Composite index (^GSPTSE)
74.39%
5-Year Return
NGMD.V
95.45%
S&P/TSX Composite index (^GSPTSE)
75.07%
Statistics
View MoreValuation Measures
As of 2026-07-14
Market Cap
4.54M
Enterprise Value
20.63M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
27.40
Price/Book (mrq)
--
Enterprise Value/Revenue
124.47
Enterprise Value/EBITDA
13.85
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-37.47%
Return on Equity (ttm)
--
Revenue (ttm)
165.74k
Net Income Avi to Common (ttm)
-11.02M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.78M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.72M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.